US Broker Ratings

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 116% Upside in Biotech Innovation

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is making waves within the healthcare industry. The company, based in Hampton, New Jersey, is dedicated to the..

Novavax, Inc. (NVAX) Stock Analysis: Assessing a 48% Potential Upside Amidst Market Challenges

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, is recognized for its innovative approach to vaccine development. With a market capitalization of $1.41 billion, Novavax operates from..

Wave Life Sciences Ltd. (WVE): Analyst Consensus Highlights 143.73% Potential Upside for Biotech Innovator

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative approach to RNA medicine development. The Singapore-based clinical-stage company is gaining investor attention, particularly..

Edgewise Therapeutics (EWTX): Analyst Consensus Reveals a 32% Upside Potential

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a dynamic presence in the biotechnology sector, is drawing significant attention in the investment community. Specializing in the development of therapies for muscle disorders, this..

Integra LifeSciences Holdings C (IART) Stock Analysis: A 38.89% Potential Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Princeton, New Jersey, Integra LifeSciences has carved..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a Potential 226.80% Upside

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), a prominent player in the specialty and generic drug manufacturing industry, presents an intriguing investment opportunity with its potential upside of 226.80%. This North Carolina-based..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Market Volatility and Growth Challenges

10x Genomics, Inc. (NASDAQ: TXG) is a prominent player in the healthcare sector, specifically within the health information services industry. The company, headquartered in Pleasanton, California, has carved a niche..

MannKind Corporation (MNKD) Stock Analysis: A Promising 59.92% Upside with Strong Buy Ratings

MannKind Corporation (NASDAQ: MNKD) stands out in the biotechnology sector with its innovative focus on therapeutic products for endocrine and orphan lung diseases. Based in Danbury, Connecticut, MannKind has carved..

Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 77.43% Potential Upside Amidst Innovative Drug Discovery and Software Growth

Schrodinger, Inc. (NASDAQ: SDGR), a pivotal player in the healthcare sector’s Health Information Services industry, is capturing investor attention with a striking 77.43% potential upside. This New York-based company, founded..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 16% Potential Upside

Kestra Medical Technologies, Ltd. (KMTS) stands at the intersection of healthcare innovation and investment opportunity. This Kirkland, Washington-based company, with a market capitalization of $1.46 billion, is making notable strides..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Promising 37.97% Upside Awaits Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a notable player in the healthcare industry, specifically within the drug manufacturing sector, presents an intriguing opportunity for investors seeking growth in the biopharmaceutical space...

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a Potential 25.73% Upside with Promising CNS Portfolio

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, specializes in developing and commercializing innovative treatments for central nervous system (CNS) diseases. With a market capitalization of $2.8..

Agios Pharmaceuticals (AGIO): Investor Outlook on a Biotech with 30.5% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative approach to cellular metabolism and promising pipeline of treatments. With a market capitalization of $1.64..

LivaNova PLC (LIVN) Stock Analysis: Promising 9.35% Upside as Healthcare Innovator Surges

LivaNova PLC (NASDAQ: LIVN), the UK-based medical device company, is making waves in the healthcare sector with a robust growth trajectory and an impressive market capitalization of $3.65 billion. Specializing..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 23.95% Potential Upside in the Medical Devices Sector

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector’s medical devices industry, offers intriguing investment potential with a notable 23.95% upside based on current analyst ratings. Headquartered in..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Unpacking a 165% Potential Upside in the Biotech Arena

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing investor attention with its compelling potential upside of 165.03%, as analysts set an average target price of $24.25, significantly higher than its current..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Unlocking a 71% Upside Potential in Bioelectric Medicine

Pulse Biosciences, Inc. (NASDAQ: PLSE), a leading player in the bioelectric medicine sector, is capturing the attention of investors with its promising technology and significant upside potential. Despite its current..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 16.84% Potential Upside in Medical Devices

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a leading name in the healthcare sector, is capturing the attention of investors with its innovative approach to medical devices, particularly in the field..

The Pennant Group, Inc. (PNTG) Stock Analysis: Analysts Predict 32.88% Upside for Healthcare Innovator

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector, specifically within the medical care facilities industry. With its headquarters in Eagle, Idaho, and operations spread across..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds